Paul Ahmed 对比(PAC)研究在难治性儿童青光眼中的初步结果
一项两中心随机对照试验比较 Paul 青光眼植入物(PGI)与 Ahmed 青光眼阀(AGV)在难治性儿童青光眼中的有效性和安全性。44 例(44 眼)完成术后一年随访,PGI 组 25 例、AGV 组 19 例。术后一年两组平均眼压、降眼压药物数量、成功率和并发症发生率均无统计学显著差异。
要点
- 术后一年平均眼压 PGI 组 14.9±4.1 mmHg vs AGV 组 15.5±3.5 mmHg,P=.6。
- 术后一年降眼压药物数量 PGI 组 1.1±1 vs AGV 组 1.6±1.03,P=.1。
- 成功率 PGI 组 80% vs AGV 组 73.6%,P=.2;两组并发症均为 3 眼。
核心结论
- 术后一年,PGI 与 AGV 在眼压下降、降眼压药物减少、成功率和并发症发生率方面相当。
研究设计与样本
- 随机对照试验,设两个临床中心,纳入 ≤18 岁计划行青光眼引流植入物手术的难治性儿童青光眼患者。
- 患者随机接受 PGI 或 AGV,本报告纳入完成术后一年随访的 44 例(44 眼),PGI 组 25 例 vs AGV 组 19 例。
- 主要结局为眼压下降,次要结局包括降眼压药物减少、成功率和并发症发生率。
- 成功率定义为术后眼压 6-21 mmHg(不用或使用最多三种局部降眼压药物)、无需额外青光眼手术、无视威胁性并发症或疾病进展证据;使用口服降眼压药如乙酰唑胺视为失败。
主要发现
- 术前平均眼压 PGI 组 32.6±6.1 mmHg vs AGV 组 29.8±6.1 mmHg(P=.1),平均降眼压药物 PGI 组 3.6±0.6 vs AGV 组 3.4±0.7(P=.35)。
- 术后一年平均眼压 PGI 组 14.9±4.1 mmHg vs AGV 组 15.5±3.5 mmHg(P=.6),降眼压药物数量 PGI 组 1.1±1 vs AGV 组 1.6±1.03(P=.1),均无统计学显著差异。
- 成功率 PGI 组 80% vs AGV 组 73.6%(P=.2),无统计学显著差异。
- 术后并发症发生率两组相当,每组各 3 眼。
- 手术时平均年龄 96.9±59.1 个月,PGI 组 90.5±60.04 个月 vs AGV 组 105.4±58.5 个月。
关键数值与推荐
- 成功率定义:术后眼压 6-21 mmHg,不用或使用最多三种局部降眼压药物,无需额外青光眼手术,无视威胁性并发症或疾病进展证据。
- 使用口服降眼压药如乙酰唑胺视为失败。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To compare the effectiveness and safety of the Paul glaucoma implant (PGI) to the Ahmed glaucoma valve (AGV) in managing refractory childhood glaucoma. DESIGN: Randomized controlled trial. SETTING: Two clinical centers. METHODS: An ongoing randomized controlled trial including patients ≤ 18 years with refractory childhood glaucoma in whom glaucoma drainage implant surgery was planned. Patients were randomized to receive either PGI or AGV. The primary outcome was the intraocular pressure (IOP) reduction. Secondary outcomes included glaucoma medication reduction, success rate, and complications rate. The success rate was defined as achieving a postoperative IOP between 6-21 mmHg without or with glaucoma medications (up to three topical glaucoma medications), without the need for additional glaucoma surgeries, and without the occurrence of vision-threatening complications or evidence of disease progression. The use of oral glaucoma medications, such as acetazolamide, was considered a failure. RESULTS: The current report included 44 patients (44 eyes) who completed the one-year postoperative follow-up (25 in the PGI group versus 19 in the AGV group). The mean age at the time of surgery was 96.9 ± 59.1 months (90.5 ± 60.04 months in the PGI group and 105.4 ± 58.5 months in the AGV group). Preoperatively, the mean IOP was 32.6 ± 6.1 mmHg with a mean of 3.6 ± 0.6 glaucoma medications in the PGI group, compared with 29.8 ± 6.1 mmHg (P = .1) with a mean of 3.4 ± 0.7 glaucoma medications (P = .35) in the AGV group. At one year, there were no statistically significant differences in the mean IOP (14.9 ± 4.1 mmHg in the PGI group versus 15.5 ± 3.5 in the AGV group, P = .6) and number of glaucoma medications (1.1 ± 1 in the PGI group versus 1.6 ± 1.03 in the AGV group, P = .1). The success rate of PGI was 80% versus 73.6% in the AGV (P = .2). The postoperative complications rate was comparable in both groups (three eyes in each group). CONCLUSION/RELEVANCE: At one year postoperatively, the IOP reduction, reduction of glaucoma medications, success rates, and rate of complications were comparable between both groups.
引用
- Elhusseiny AM, Khaled OM, Chauhan MZ, et al. Initial Results of the Paul Ahmed Comparison (PAC) Study in Refractory Childhood Glaucoma. Am J Ophthalmol. 2024. PMID: 39510370. doi:10.1016/j.ajo.2024.10.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。